Search
for
Sort by
Research 31–60 of 1000+
- Cutaneous Appendage Damage after Herpes Zoster
- Rapidly Progressive Alopecia Universalis after Varicella-Zoster Virus Infection: The role of Immune Dysregulation and Tofacitinib treatment
- Alopecia following oral acyclovir for the treatment of herpes simplex keratitis
- Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China
- Clinical Significance of Dense Fine Speckled Pattern in Anti-nuclear Antibody Test using Indirect Immunofluorescence Method
- A CLINICAL STUDY OF MUCOCUTANEOUS MANIFESTATIONS OF HIV
- Operational research on the correlation between skin diseases and HIV infection in Tigray region, Ethiopia
- Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
- Comparison of patients’ diagnoses in a dermatology outpatient clinic during the COVID‐19 pandemic period and pre‐pandemic period
- Change of the diagnostic distribution in applicants to dermatology after COVID ‐19 pandemic: What it whispers to us?
- British Hair and Nail Society
- Cepharanthine Suppresses Herpes Simplex Virus Type 1 Replication Through the Downregulation of the PI3K/Akt and p38 MAPK Signaling Pathways
- Localization of varicella-zoster virus nucleic acids and proteins in human skin
- A clinical study of Geriatric dermatoses at Tertiary care center in South India
- Dermatological Issues Among Individuals Receiving Palliative Care - A Review
- Dietary Management of Skin Diseases
- Dermatologic therapy: December 1986 to December 1987
- Mucocutaneous manifestations in children with human immunodeficiency virus infection
- Atlas of Geriatric Dermatology
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- Alopecia cicatrizal como manifestación de lupus eritematoso cutáneo
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Alopecia
- JAK inhibitors and alopecia areata
- Secondary cicatricial and other permanent alopecias
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Primary cicatricial alopecia
- Cicatricial alopecia